![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Issue contents]](/e/graphics/issuecontentsborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](at2605contents.gif)
Acta Cryst. (2008). E64, o1750 [ doi:10.1107/S1600536808025154 ]
Abstract: The title compound [systematic name: 2-(imidazol-1-ylmethyl)isoindole-1,3-dione], C12H9N3O2, was prepared by reaction of N-(bromomethyl)phthalimide and imidazole in chloroform solution. The crystal structure is stabilized by weak intermolecular C-H
![[pi]](/logos/entities/pi_rmgif.gif)
interactions and intermolecular - interactions with centroid-centroid distances in the range 3.6469 (8)-3.8831 (9) Å.
Online 13 August 2008
Copyright © International Union of Crystallography
IUCr Webmaster